rTMS for Epilepsy: What a Review Found About Short-Term Seizure Reduction
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
This systematic review and meta-analysis compared two procedures for drug-resistant epilepsy caused by MRI-positive focal cortical dysplasia type II (FCD II) or tuberous sclerosis complex (TSC).
This systematic review examined whether déjà vu, déjà vécu, dreamy states, and reminiscence during focal seizures can help identify the epileptogenic zone.
Researchers combined results from 48 studies involving 822 people with Lennox-Gastaut syndrome across 19 countries.
This systematic review and meta-analysis examined neuromodulation treatments for people younger than 18 years with drug-resistant epilepsy.
Researchers studied how often children were not recommended for epilepsy surgery and whether recommendations differed among epilepsy centers.
This systematic review examined medium-chain triglyceride (MCT)-based interventions for people with drug-resistant epilepsy.
This article was a critical review, not a new clinical trial, and the abstract does not report enrolling participants.
This narrative review brought together published research on early infantile developmental and epileptic encephalopathy (EIDEE), a severe epilepsy syndrome beginning before 3 months of age.